IL-20 antagonist suppresses PD-L1 expression and prolongs survival in pancreatic cancer models

The pro-inflammatory cytokine IL-20 promotes tumor growth in several cancer types. Here, the authors show that high levels of IL-20 are associated with poor survival in patients with pancreatic ductal adenocarcinoma (PDAC) and that IL-20 blockade reduces tumor growth and alleviates cachexia symptoms...

Full description

Saved in:
Bibliographic Details
Main Authors: Shao-Wei Lu, Hong-Chin Pan, Yu-Hsiang Hsu, Kung-Chao Chang, Li-Wha Wu, Wei-Yu Chen, Ming-Shi Chang
Format: article
Language:EN
Published: Nature Portfolio 2020
Subjects:
Q
Online Access:https://doaj.org/article/daecbc35c3a24e828aa4c37a7583f7d1
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items